This webinar provides an overview of the wide array of scalable technologies that are available for modified-release dosage forms and describes how to match technology strengths with API properties using biological modeling. Dosage-form technologies include tablets and multiparticulates and release profiles includes continuous (e.g., zero order, first order) and pulsatile (e.g., for taste-masking, enteric, or delayed-release applications).